Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years.
about
Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@en
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@nl
type
label
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@en
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@nl
prefLabel
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@en
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@nl
P2093
P2860
P1433
P1476
Development of Insulin Detemir ...... pe 1 Diabetes Aged 2-16 Years.
@en
P2093
Abdullah Bereket
Line Conradsen Hiort
Lisbeth Bjerring Jensen
Valentina Peterkova
P2860
P2888
P304
P356
10.1007/S13300-016-0196-5
P577
2016-09-06T00:00:00Z